Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Platelet-derived growth factor BB (PDGF-BB) is a biologically active, dimeric protein composed of two B chains from the PDGF family. It acts as a potent mitogen and chemoattractant for cells of mesenchymal origin, including fibroblasts and smooth muscle cells. PDGF-BB binds to the platelet-derived growth factor receptor (primarily PDGFR-beta), activating intracellular signaling pathways that regulate cell proliferation, migration, survival, and differentiation. It plays essential roles in embryonic development, angiogenesis, wound healing, tissue repair, and vascular remodeling. Recombinant forms of PDGF-BB are produced for research purposes and have been investigated clinically for their regenerative properties in chronic wounds (such as diabetic ulcers), bone fractures, periodontal defects, and neurodegenerative diseases like Parkinson’s disease[2][4][5][6][8]. The mechanism involves stimulation of cellular processes critical to tissue regeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on platelet-derived growth factor BB.